Recorded fact · drug.label_indication
drug.label_indication for risdiplam|spinal-muscular-atrophy
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 97f05cdd resolves to.
The record
| Fact id | 97f05cdd5ea41c1db3f1a9f8 |
|---|---|
| Entity | drug: risdiplam|spinal-muscular-atrophy |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260219 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 9dbf87b740c12822785c4f96219927b32db664a520a1d299e32363bad931d327.
The value
{
"ingredient": "Risdiplam",
"conditionId": "spinal-muscular-atrophy",
"conditionName": "Spinal muscular atrophy",
"matchedAlias": "spinal muscular atrophy",
"context": "indication",
"brand": "EVRYSDI",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "eceb9a99-7191-4be5-87c3-0102707cf98e",
"labelEffectiveTime": "20260219",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: d4adb3f6d7943a71f2718a765362d505f436c5734d3896383d83122652aef48e.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.